AARTI PHARMALABS LIMITED
L24100GJ2019PLC110964
DataDelta records 2 directors, 28 financial line items, 126 NSE events, and 0 group companies for AARTI PHARMALABS LIMITED. Appointment dates and ownership percentages are withheld until they pass a data-quality check.
- ISIN
- INE0LRU01027
- NSE
- AARTIPHARM
- BSE
- 543748
- Listing
- Listed
- Status
- Active
- State
- gujarat
- Class
- Public
- Industry
- Manufacturing (Metals and Chemicals, and products thereof)
Events
50 shown of 126
| Date | Type | Status | Title |
|---|---|---|---|
| 2026-09-23 | ShareholderMeeting | Completed | Aarti Pharmalabs Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 22, 2026. Further, the company has informed the Exchange regarding voting results. |
| 2026-09-23 | BoardChange | Announced | Aarti Pharmalabs Limited has informed the Exchange regarding 'Updates on Change in Directorate'. |
| 2026-09-22 | ShareholderMeeting | Completed | Aarti Pharmalabs Limited has informed the Exchange regarding 'Presentation made to the shareholders at 7th AGM'. |
| 2026-09-22 | ShareholderMeeting | Completed | Aarti Pharmalabs Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 22, 2026 |
| 2026-09-15 | Dividend | Completed | Dividend - Rs 2 Per Share |
| 2026-08-31 | Disclosure | Announced | Aarti Pharmalabs Limited has informed the Exchange about change in Management |
| 2026-08-31 | BoardChange | Announced | Aarti Pharmalabs Limited has informed the Exchange about Resignation of Director/KMP/SMP |
| 2026-08-29 | ShareholderMeeting | Completed | Aarti Pharmalabs Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 22, 2026 |
| 2026-08-17 | Dividend | Completed | Aarti Pharmalabs Limited has informed the Exchange that Record date for the purpose of Dividend is 15-Sep-2026. |
| 2026-08-07 | BoardMeeting | Completed | Aarti Pharmalabs Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. |
| 2026-08-07 | BoardChange | Announced | Aarti Pharmalabs Limited has informed the Exchange regarding Change in Director(s) of the company. |
| 2026-08-07 | BoardChange | Announced | Aarti Pharmalabs Limited has informed the Exchange regarding Change in Director(s) of the company. |
| 2026-07-28 | BoardMeeting | Completed | Aarti Pharmalabs Ltd has informed the Exchange about Board Meeting to be held on 07-Aug-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2026 . |
| 2026-07-28 | FinancialResults | Completed | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 2026-06-30 | Disclosure | Announced | Aarti Pharmalabs Limited has informed the Exchange regarding a press release dated Jun 30, 2026, titled Aarti Pharmalabs Limited inaugurates its new state-of-the-art additional manufacturing block at Tarapur Unit 5, Maharashtra to expand its production capacity. |
| 2026-06-24 | TradingWindow | Announced | Aarti Pharmalabs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 2026-06-24 | Allotment | Completed | Aarti Pharmalabs Limited has informed the Exchange regarding allotment of 22062 securities pursuant to ESOP/ESPS at its meeting held on Jun 24, 2026 |
| 2026-06-22 | Acquisition | Announced | Chandrakant Vallabhaji Gogri has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
| 2026-06-12 | Acquisition | Announced | Chandrakant Vallabhaji Gogri has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
| 2026-05-25 | ESOP | Announced | Aarti Pharmalabs Limited has informed the Exchange regarding Grant of 57600 Options. |
| 2026-05-25 | BoardMeeting | Completed | Aarti Pharmalabs Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. |
| 2026-05-25 | Dividend | Completed | Aarti Pharmalabs Limited has informed the Exchange that Board of Directors at its meeting held on May 25, 2026, recommended Final Dividend of Rs. 2 per equity share. |
| 2026-05-25 | Appointment | Announced | Aarti Pharmalabs Limited has informed the Exchange about Re-appointment of Cost Auditor & Internal Auditor for FY 2026-2027 |
| 2026-05-25 | Disclosure | Announced | Aarti Pharmalabs Limited has informed the Exchange about change in Management |
| 2026-05-14 | Dividend | Completed | AARTIPHARM : 25-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 18, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 25, 2026, To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| 2026-05-14 | Dividend | Completed | Aarti Pharmalabs Ltd has informed the Exchange about Board Meeting to be held on 25-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend/Other business. |
| 2026-05-11 | Dividend | Completed | To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| 2026-05-11 | Dividend | Completed | Aarti Pharmalabs Ltd has informed the Exchange about Board Meeting to be held on 18-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend/Other business. |
| 2026-03-25 | TradingWindow | Announced | Aarti Pharmalabs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 2026-02-16 | Dividend | Completed | Interim Dividend - Rs 1.50 Per Share |
| 2026-02-10 | Dividend | Completed | Aarti Pharmalabs Limited has informed the Exchange regarding 'Corrigendum to Intimation of Record Datefor Dividend dated February 09, 2026'. |
| 2026-02-09 | Dividend | Completed | Aarti Pharmalabs Limited has informed the Exchange that Board of Directors at its meeting held on February 09, 2026, declared Interim Dividend of Rs. 1.5 per equity share. |
| 2026-02-09 | Dividend | Completed | Aarti Pharmalabs Limited has informed the Exchange that Record date for the purpose of Dividend is 16-Feb-2026. |
| 2026-02-09 | Allotment | Completed | Aarti Pharmalabs Limited has informed the Exchange regarding Allotment of 10457 Shares. |
| 2026-02-09 | BoardMeeting | Completed | Aarti Pharmalabs Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025. |
| 2026-01-29 | Dividend | Completed | AARTI PHARMALABS LIMITED has informed the Exchange about Board Meeting to be held on 09-Feb-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 31, 2025 and Dividend/Other business. |
| 2026-01-29 | Dividend | Completed | Aarti Pharmalabs Limited has informed the Exchange about Board Meeting to be held on 09-Feb-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2025 and Dividend. |
| 2026-01-12 | Disclosure | Announced | Significant increase in volume has been observed in Aarti Pharmalabs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Aarti Pharmalabs Limited has submitted their response. |
| 2026-01-09 | Disclosure | Announced | Significant increase in volume has been observed in Aarti Pharmalabs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. |
| 2026-01-01 | Disclosure | Announced | Aarti Pharmalabs Limited has informed the Exchange about change in Management |
| 2025-12-22 | TradingWindow | Announced | Aarti Pharmalabs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 2025-11-09 | Disclosure | Announced | Aarti Pharmalabs Limited has informed the Exchange about change in Management |
| 2025-11-09 | BoardMeeting | Completed | Aarti Pharmalabs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. |
| 2025-10-27 | FinancialResults | Completed | To consider and approve the unaudited standalone and consolidated financial results for the period ended September 30, 2025 |
| 2025-10-27 | BoardMeeting | Completed | AARTI PHARMALABS Limited has informed the Exchange about Board Meeting to be held on 09-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2025 . |
| 2025-10-15 | FinancialResults | Completed | The Exchange had sought clarification from Aarti Pharmalabs Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed. |
| 2025-10-13 | Allotment | Completed | Aarti Pharmalabs Limited has informed the Exchange regarding Allotment of 6070 Shares. |
| 2025-09-25 | TradingWindow | Announced | Aarti Pharmalabs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 2025-09-23 | ShareholderMeeting | Completed | Aarti Pharmalabs Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 22, 2025 |
| 2025-09-23 | Disclosure | Announced | Aarti Pharmalabs Limited has informed the Exchange about change in Management |
Directors
2 shown of 2
| Name | DIN | Designation | Status |
|---|---|---|---|
| Rajendra V. Gogri | 00061003 | Independent Director | Active |
| have re-designated Shri Rashesh C. Gogri | 00066291 | Whole-time Director | Active |
Financials
28 shown of 28
| Year | Metric | Value | Unit |
|---|---|---|---|
| 2025-26 | CostOfMaterials | 83,006.36 | Lakhs |
| 2025-26 | CostOfMaterials | 83,453.22 | Lakhs |
| 2025-26 | Depreciation | 10,429.86 | Lakhs |
| 2025-26 | EmployeeBenefits | 17,048.01 | Lakhs |
| 2025-26 | EmployeeBenefits | 17,309.31 | Lakhs |
| 2025-26 | ProfitBeforeTax | 23,292.12 | Lakhs |
| 2025-26 | Revenue | 1,79,755.17 | Lakhs |
| 2025-26 | Revenue | 1,81,944.25 | Lakhs |
| 2025-26 | Tax | 5,803.7 | Lakhs |
| 2025-26 | Tax | 5,821.39 | Lakhs |
| 2025-26 | TotalExpenses | 1,57,584.11 | Lakhs |
| 2025-26 | TotalExpenses | 1,60,147.11 | Lakhs |
| 2025-26 | TotalIncome | 1,82,918.89 | Lakhs |
| 2025-26 | TotalIncome | 1,81,287.5 | Lakhs |
| 2024-25 | CostOfMaterials | 75,639.88 | Lakhs |
| 2024-25 | CostOfMaterials | 83,579.79 | Lakhs |
| 2024-25 | Depreciation | 7,905.91 | Lakhs |
| 2024-25 | EmployeeBenefits | 15,288.19 | Lakhs |
| 2024-25 | EmployeeBenefits | 16,195.95 | Lakhs |
| 2024-25 | ProfitBeforeTax | 36,068.95 | Lakhs |
| 2024-25 | Revenue | 2,11,507.45 | Lakhs |
| 2024-25 | Revenue | 1,77,135.18 | Lakhs |
| 2024-25 | Tax | 7,899.23 | Lakhs |
| 2024-25 | Tax | 8,828.47 | Lakhs |
| 2024-25 | TotalExpenses | 1,44,780.76 | Lakhs |
| 2024-25 | TotalExpenses | 1,76,281.08 | Lakhs |
| 2024-25 | TotalIncome | 2,12,350.04 | Lakhs |
| 2024-25 | TotalIncome | 1,78,414.86 | Lakhs |
Group companies
0 shown of 0
| Company | Relationship | Country |
|---|